CorMedix Inc
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -3,533.5% | – | -1,741.7% | -119.1% | -18.0% | 50.5% | 75.5% | 29.6% | 73.4% | 33.3% | 84.6% | 54.9% | |
| – | 6.1% | – | 9.5% | 0.7% | 0.4% | 0.4% | 0.4% | 3.6% | 8.1% | 8.3% | -10.3% | 3.1% | |
| – | 400.3% | – | 156.8% | 10.7% | 3.8% | 9.0% | 6.7% | 3.9% | 2.8% | 3.6% | -4.5% | 1.7% | |
| – | 900.2% | – | -157.0% | -106.6% | -65.9% | -11.8% | 18.3% | -24.6% | 23.6% | -25.5% | 32.1% | 1.1% | |
| – | 97.3% | – | 4.3% | 0.1% | 0.0% | 0.0% | 0.1% | 0.5% | 1.3% | 0.6% | 0.7% | 0.8% | |
| – | 196.6% | – | 777.6% | 55.2% | -1.0% | -0.5% | -50.9% | -279.4% | 2.6% | 2.3% | -0.6% | -61.8% | |
| – | 0.0% | – | -17.3% | 2.1% | – | 0.0% | 0.0% | – | – | -8.7% | 10.9% | – | |
| – | – | – | – | – | – | – | – | – | 0.0% | – | – | – | |
| – | 153.8% | – | 131.1% | 122.9% | 36.2% | 15.6% | 209.5% | 144.4% | -1.1% | -9.5% | -6.9% | 28.1% | |
| – | -3,182.3% | – | -833.0% | 58.9% | 17.2% | 65.6% | 234.1% | -105.4% | 74.9% | 26.1% | 77.1% | 21.3% | |
| – | -3,630.8% | – | -1,746.0% | -119.2% | -18.0% | 50.5% | 75.4% | 29.1% | 72.1% | 32.7% | 85.3% | 54.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.